Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Wells Fargo Healthcare Conference Transcript

Sep 05, 2019 / 01:45PM GMT
Release Date Price: €116.88 (+0.36%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst

Good morning, everyone. I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. And it's my pleasure to host this session with Johnson & Johnson. With us this morning, we have Ashley McEvoy, Executive Vice President, Worldwide Chairman of Medical Devices. The format is going to be fireside chat. If anyone in the audience has a question, please raise your hand and we'll come around. Before -- but before we jump in to questions, Matt Stuckley, from Investor Relations, is going to read the forward-looking statement.

Matthew Stuckley
Johnson & Johnson - Senior Director of IR

Thanks, Larry, and good morning, everyone. Please be aware that some statements made today may be considered forward-looking or utilize non-GAAP measures. Please refer to our SEC filings, in particular our 10-K, which discuss the risks and uncertainties around forward-looking statements as well as our website at investor.jnj.com for reconciliations to comparable GAAP measures. Finally, any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot